Search clinical trials for: Major adverse cardiovascular and cerebrovascular events

Total 474186 results

University of Roma La Sapienza
University of Florence

Unknown

Retinal Thrombosis and Atherosclerosis (HEART-VISION)

Retinal Vein Occlusion

Italy
First Affiliated Hospital Xi'an Jiaotong University
LanZhou University; Shaanxi Provincial People's Hospital; General Hospital of... and other collaborators

Unknown

The Impact of Depression and/or Anxiety on PCI Patients

Depression | Anxiety | Acute Coronary Syndrome

China
Dongying Zhang

Completed

The Eosinophils Percentage Predicts In-hospital Major Adverse Cardiac Events in STEMI Patients After PCI

ST Elevation Myocardial Infarction
Yan Zhou, MD

Completed

Analysis of Incidence and Risk Factors of Severe Cardiovascular Events in Patients With Diastolic Dysfunction

Diastolic Dysfunction

China
Canadian Network for Observational Drug Effect...
Canadian Institutes of Health Research (CIHR); Drug Safety and Effectiveness...

Completed

Direct Oral Anticoagulants and Venous Thromboembolism

Venous Thromboembolism | Major Bleed

Canada
Vanderbilt University

Terminated

Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease

Coronary Artery Disease

United States
Eighth Affiliated Hospital, Sun Yat-sen University
Xiangya Hospital of Central South University; Shanghai 10th People's Hospital; Second Affiliated Hospital of Zhengzhou University and other collaborators

Unknown

Effect of External Counter Pulsation on Coronary Artery Disease (ECP-CAD)

Coronary Artery Disease | Stable Chronic Angina

China
Baim Institute for Clinical Research
Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Boston Scientific... and other collaborators

Completed

The Dual Antiplatelet Therapy Study (DAPT Study)

Coronary Artery Disease

United States, Australia, Czechia, New Zealand, United Kingdom, Germany, Hungary, Poland, France, Romania
GlaxoSmithKline
The TIMI Study Group

Completed

A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60) (LATITUDE)

Acute Coronary Syndrome

United States, Australia, France, Spain, Taiwan, Estonia, Poland, Russian Federation, Belgium, Philippines, Sweden, Thailand, Germany, Israel, Bulgaria, Hong Kong, Netherlands, Norway, Slovakia, South Africa, Korea, Republic of, R... and more
University of Arizona

Withdrawn

T2 Heart Mapping in AMI Population for the Prediction of Short Term Major Adverse Cardiovascular Events (T2 AMI MRI)

Myocardial Infarction, Acute

United States
General Hospital of Chinese Armed Police Forces

Completed

Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

Non ST Segment Elevation Acute Coronary Syndrome

China
Daewoong Pharmaceutical Co. LTD.

Withdrawn

Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule)

Metabolic Syndrome

Korea, Republic of
Seoul St. Mary's Hospital
AstraZeneca; The Catholic University of Korea; Chonnam National University

Unknown

CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)

Bleeding | Percutaneous Coronary Intervention | Acute Myocardial Infarction | Major Adverse Cardiovascular Events

Korea, Republic of
Elpen Pharmaceutical Co. Inc.

Completed

Antiplatelet Therapy Following Stent Implantation (Anti-Clot)

Angina, Unstable | Acute Myocardial Infarction | Coronary Syndrome

Greece
Merck Sharp & Dohme LLC
Duke Clinical Research Institute

Terminated

The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED) (RED-CABG)

Myocardial Infarction | Stroke | Coronary Artery Bypass | Ventricular Dysfunction, Left | Cardiopulmonary Bypass
European Society of Anaesthesiology
Erasmus Medical Center; University of Leeds

Completed

Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery (OBTAIN)

Thrombosis | Bleeding | Cardiac Events

Germany, Netherlands, United Kingdom
Qilu Hospital of Shandong University
Beijing Friendship Hospital; Qingdao University; Ruijin Hospital; Shandong Provincial... and other collaborators

Completed

Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling (PMIR-miR-126)

Myocardial Infarction | Left Ventricular Remodeling | miR-126

China
University Health Network, Toronto
Anesthesia Patient Safety Foundation

Completed

The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery

Thrombosis

Canada
Mid Western Regional Hospital, Ireland

Completed

Preconditioning Shields Against Vascular Events in Surgery (SAVES)

Carotid Atherosclerosis | Abdominal Aortic Aneurysm | Critical Lower Limb Ischaemia

Ireland
University Hospital Heidelberg

Withdrawn

Pre-discharge vs. Early Post-discharge Stress Testing and GRACE Score for Safe Discharge of ACS-patients With a Negative Hs-troponin T Result

Major Adverse Cardiovascular Events | Troponin T | GRACE Score

Germany
Capital Medical University

Completed

Relationship of Helicobacter Pylori Eradication Therapy and Long-term Outcome in Acute Coronary Syndrome

Acute Coronary Syndrome
Mid Western Regional Hospital, Ireland

Unknown

Preconditioning Shields Against Vascular Events in Surgery (SAVES-F)

Carotid Atherosclerosis | Abdominal Aortic Aneurysm | Critical Lower Limb Ischaemia

Ireland
GlaxoSmithKline

Completed

SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)

Coronary Heart Disease
Novartis Pharmaceuticals

Terminated

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People (APOLLO)

Cardiovascular Events

Colombia, India, South Africa, Canada, Spain, Hungary, United States, Germany, Ireland, Argentina, Philippines, Brazil, Sweden, Malaysia, Chile, Israel, Czech Republic, Netherlands
Central South University

Unknown

Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR (ARMYDA-IMR)

Stable Angina | Unstable Angina | Acute Non-ST-segment Elevation Myocardial Infarction

China
University of Zagreb

Completed

Resistance on Antithrombotic Drugs in Ischemic Heart Disease

Coronary Artery Disease

Croatia
Les Laboratoires des Médicaments Stériles

Completed

Clinical Assessment of Pidogrel® Versus Plavix® (CAPP) ((CAPP))

Coronary Disease

Tunisia
Assistance Publique Hopitaux De Marseille

Completed

Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention

Cardiovascular Diseases | Atherosclerosis | Percutaneous Coronary Intervention

France
Sir Run Run Shaw Hospital

Unknown

Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation (EASTS)

Coronary Artery Disease
Positive Trial Group

Terminated

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments (POSITIVE)

Hypertension | Type 2 Diabetes | Hypercholesterolemia

Japan
JW Medical Systems Ltd

Unknown

A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions (EVOLUTION)

Myocardial Infarction | Ischemia | Cardiac Death

China
Showa University

Completed

Comparison Between Pioglitazone and SES With type2 DM

Coronary Artery Disease | Type 2 Diabetes Mellitus
Pfizer
Diabetes UK; Department of Health, United Kingdom

Completed

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events (CARDS)

Angina, Unstable | Cerebrovascular Accident | Coronary Artery Bypass Graft | Revascularization | Major Coronary Event

United Kingdom
University of Zagreb

Completed

Comparison of Stent Graft, Sirolimus Stent, and Bare Metal Stent Implanted in Patients With Acute Coronary Syndrome

Acute Coronary Syndrome

Croatia
Beijing Tiantan Hospital

Recruiting

Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ(TRACE Ⅳ)

Minor Ischemic Stroke | Tenecteplase

China
The First Affiliated Hospital of Xinxiang Medical...

Not yet recruiting

Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA) (PARCA)

Cardiovascular Diseases | Vascular Diseases | Cancer | Cardiac Diseases
Mahidol University
Health Systems Research Institute; The Heart Association of Thailand

Not yet recruiting

COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2

Atrial Fibrillation

Thailand
University Hospital, Basel, Switzerland

Not yet recruiting

PeRforation EVents During ENdovascular Therapy for Acute Ischemic Stroke (PREVENT)

Acute Ischemic Stroke | Periprocedural Vessel Perforation

Switzerland
Cantonal Hospital of St. Gallen

Recruiting

Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment - a Collaborative Observational Research Project

Brain Tumor | Aneurysm | Disc Disease | Instabilities Lumbar

Switzerland
Kafrelsheikh University

Recruiting

Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction

Ischemic Stroke | Alteplase Adverse Reaction

Egypt
Beijing Tiantan Hospital

Not yet recruiting

Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）

TIA | Ischemic Stroke, Acute | Symptomatic Intracranial Artery Stenosis

China
Amgen

Recruiting

A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease

Major Cardiovascular Event | Established Atherosclerotic Cardiovascular Disease

China
University Hospital, Toulouse

Not yet recruiting

International Multicenter Project Comparing Radiofrequency Ablation Versus Implantable Defibrillator After Well-tolerated Ventricular Tachycardia in Ischemic Heart Disease With Minimally Impaired Ejection Fraction (VIVA)

Ischemic Heart Disease | Ventricular Tachycardia
Zhujiang Hospital

Recruiting

Dynamic Changes in Human Microbiome Predict the Risk of Adverse Outcomes in Patients With Acute Ischemic Stroke: a Multicenter Prospective Cohort Study

Acute Ischemic Stroke

China
Beijing Tiantan Hospital

Recruiting

Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR)

Unruptured Intracranial Aneurysm | Thromboembolic Events | Flow Diverter | Stent-assisted Coiling

China
AbbVie

Recruiting

Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

Israel
University Hospital, Toulouse

Recruiting

Neurofeedback-EEG Rehabilitation Protocol on Motor Recovery in the Subacute Phase Post-stroke (CUSTOM-NF-STROKE)

Cerebrovascular Accident

France
Beijing Tiantan Hospital

Recruiting

Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5 (TRACE-5)

Ischemic Stroke, Acute

China
Institut universitaire de cardiologie et de pneumologie...

Not yet recruiting

Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study (RE-DRT)

Thromboembolic Event | Percutaneous Left Atrial Appendage Occlusion (LAAO) | Device-related Thrombus (DRT) | Major Cardioembolic Events | Major Bleeding - TIMI Classification
National Taiwan University Hospital

Recruiting

Evaluataion of NOAC Levels in Acute Stroke

Ischemic Stroke | Anticoagulant Adverse Reaction

Taiwan

Search clinical trials for: Major adverse cardiovascular and cerebrovascular events

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations